PURE Bioscience, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2011 | $-6.1M | $-6.1M | $14.0K | $1.2M |
| FY2012 | $-5.6M | $-5.6M | $10.0K | $1.1M |
| FY2013 | $-3.9M | $-3.9M | $12.0K | $720.0K |
| FY2014 | $-6.3M | $-6.3M | $21.0K | $3.0M |
| FY2015 | $-6.1M | $-6.1M | $81.0K | $2.4M |
| FY2016 | $-5.0M | $-5.4M | $390.0K | $1.9M |
| FY2017 | $-4.6M | $-4.8M | $206.0K | $1.1M |
| FY2018 | $-3.9M | $-3.9M | $19.0K | $2.4M |
| FY2019 | $-3.0M | $-3.0M | $7.0K | $2.4M |
| FY2020 | $669.0K | $611.0K | $58.0K | $787.0K |
| FY2021 | $-1.2M | $-1.7M | $521.0K | $841.0K |
| FY2022 | $-2.4M | $-2.5M | $81.0K | $567.0K |
| FY2023 | $-3.3M | $-3.3M | $33.0K | $324.0K |
| FY2024 | $-2.5M | $-2.5M | — | $214.0K |
| FY2025 | $-2.0M | $-2.0M | — | $147.0K |